Clinical Trial Update: Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial compares 14-day clarithromycin-based triple therapy with a 10-day sequential therapy as first-line regimens for Helicobacter pylori infection, f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Omeprazole (Omeprazole)
• clarithromycin (clarithromycin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Eradication Rates of the Two Regimens | Phase 4 | Status: UNKNOWN